drugset / Trial / NCT00120900
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
RandomizedParallel-groupDouble-blindTreatment
Summary
This study was designed to evaluate the effectiveness of GW406381 (a COX-2 inhibitor) in treating the signs and symptoms of osteoarthritis of the knee.
Timeline
- Start
- 2005-05
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW406381 | Small molecule | 1 mg | Oral |
| Subject | GW406381 | Small molecule | 5 mg | Oral |
| Subject | GW406381 | Small molecule | 10 mg | Oral |
| Subject | GW406381 | Small molecule | 25 mg | Oral |
| Subject | GW406381 | Small molecule | 50 mg | Oral |